An update
Robert Vassallo, MD
Mayo Clinic, Rochester, MN, USA.
Kuwait congress Update in Internal Medicine
February 2014
Disclosures
I have nothing to disclose with respect to this
presentation.
Asthma pathophysiology
1980s
Bronchospasm
+ Inflammation
1990s
present
Bronchospasm
+ Inflammation
+ Remodeling
Dendritic cells
Th17
T cell
Eosinophil
Th-2
IL-5 / IL-13
CHEST 2013; 144(3):10261032.
Bronchoprovocation testing
Methacholine, histamine, exercise
Exhaled nitric oxide (NO)
Nitric Oxide
Exhaled NO
Air trapping
Mucus plugging
Increased work of breathing
Acute Asthma
Up to 2 treatments
20 minutes apart
ER
Admit
2014 MFMER | slide-10
Asthma management
Post-hospital follow up of severe asthma
1) Identify triggers
2) Control inflammation
Corticosteroid therapy
Leukotriene inhibitors
Anti-IgE therapy
Thermoplasty
3) Provide bronchodilator
for relief
4) Assess response
sensitivity to Alternaria
low socioeconomic status or inner-city residence
illicit drug use
major psychosocial problems
Expert Panel Report 3: National Heart Lung and Blood Institute 2007
https://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
2014 MFMER | slide-20
Tiotropium
Recent double blind trial in asthmatic patients
Addition of tiotropium compared with:
Doubling inhaled steroid
Addition of salmeterol
Tiotropium increased am peak flows more than
doubling inhaled steroids and equivalent to
salmeterol.
Most secondary outcomes favored tiotropium
N Eng J Med 2010;363:1715-26
2014 MFMER | slide-22
Bronchial Thermoplasty